Skip to content
 

Blog & Resources

Pioneering Multivariate Companion Markers: Collaborative Pathways to Accelerate Market Access

Multivariate companion markers (MCMs) hold the key to unlocking precision medicine, yet their path to clinical adoption is filled with scie...

February 06, 2025

Transforming Drug Discovery: The Critical Role of Proteomics and Targeted Protein Degradation in the Future of Therapeutics

Dr. Andrew I Webb explores how advanced proteomics and Targeted Protein Degradation (TPD) are revolutionizing drug discovery, unlocking new...

October 15, 2024

Latest Articles

email newsletter icon_small2

Subscribe to the #MassGeek newsletter

We’ll send you the latest news about Mass Dynamics and the Proteomics community.

*We won’t sell your information or spam you, and you can unsubscribe at any time.